| 生物制剂治疗类天疱疮的研究进展 |
| |
| 引用本文： | 胥璟,邓丹琪. 生物制剂治疗类天疱疮的研究进展[J]. 中国麻风皮肤病杂志, 2021, 37(5): 328-331. DOI: 10.12144/zgmfskin202105328 |
| |
| 作者姓名： | 胥璟 邓丹琪 |
| |
| 作者单位： | 昆明医科大学第二附属医院皮肤性病科，云南昆明，650101 |
| |
| 摘 要： | 类天疱疮是一组自身免疫性表皮下大疱病,包括大疱性类天疱疮、黏膜类天疱疮、妊娠类天疱疮等.外用或系统应用糖皮质激素和免疫抑制剂是类天疱疮传统的治疗方法,长期使用易发生严重不良反应,近年来一些学者使用生物制剂治疗类天疱疮取得一定疗效,现将生物制剂治疗类天疱疮的研究进展进行综述.
|
| 关 键 词： | 类天疱疮 生物制剂 利妥昔单抗 |
Upadate of biologicals for treating pemphigoid |
| |
| XU Jing,DENG Danqi. Upadate of biologicals for treating pemphigoid[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(5): 328-331. DOI: 10.12144/zgmfskin202105328 |
| |
| Authors: | XU Jing DENG Danqi |
| |
| Affiliation: | Department of Dermatology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China |
| |
| Abstract: | Pemphigoid is a term for heterogeneous blistering disorders including bullous pemphigoid(BP), mucous membrane pemphigoid(MMP)，Pemphigoid gestationis(PG), etc. Conventional therapy includes systemic corticosteroids(CS) and immunosuppressive agents(ISA), which is often accompanied by significant adverse reactions after long term treatment. Many scholars have tried to use biological agents to treat pemphigoid and achieved certain efficacy. The update of biological agents in the treatment of pemphigoid is reviewed in this paper. |
| |
| Keywords: | pemphigoid biologicals rituximab |
| 本文献已被 CNKI 等数据库收录！ |
| 点击此处可从《中国麻风皮肤病杂志》浏览原始摘要信息 |
|
点击此处可从《中国麻风皮肤病杂志》下载免费的PDF全文 |
